Page 4 - Antech Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shares of  The Medicines Company (NASDAQ:MDCO) [Trend Analysis] runs in leading trade, it plunging -1.81% to traded at $35.32. The firm has price volatility of 5.58% for a week and 3.71% for a month. Its beta stands at 0.49 times. The Medicines Co (MDCO) presented compelling safety and efficacy data from Day 180 interim analysis for ORION-1 Phase 2 Study of Inclisiran. The firm reported positive top-line results from the interim analysis with Day 180 follow-up for all 501 patients enrolled in the ongoing ORION-1 Phase 2 study of inclisiran, its investigational, first-in-class PCSK9 synthesi...

Cats with chronic kidney disease can now live longer, better lives than ever before. “It’s been a very exciting time over the last decade or so in that we’ve really enhanced our abilities to diagnose and detect chronic kidney disease,” said Dr. Shelly L. Vaden, a professor of internal medicine at North Carolina State University College of Veterinary Medicine. “We’ve also made many improvements in medical management.” Dr. Vaden was speaking during the New Therapeutic Approaches to Chronic Care Symposium at the AVMA Virtual Convention 2020 this past August. Another convention pres...

Health your username December 10, 2020 In the Eastern District of California on Wednesday, Antech Diagnostics Inc. and Dr. Christian Leutenegger filed a complaint against Idexx Laboratories Inc., seeking declaratory relief related to threatened litigation by Idexx over trade secrets and Leutenegger’s contract with Idexx, his former employer. Leutenegger, a veterinary scientist who develops “quantitative polymerase chain reaction (qPCR or real-time PCR) tests” that primarily can detect and measure infections in animals,  joined Idexx in 2006 after postdoctoral work at the University of ...